Matthew L. Trerotola
Net Worth
Last updated:
What is Matthew L. Trerotola net worth?
The estimated net worth of Mr. Matthew L. Trerotola is at least $173,027,189 as of 6 Sep 2025. He owns shares worth $70,479,616 as insider, has earned $68,237,573 from insider trading and has received compensation worth at least $34,310,000 in companies like Enovis Corporation, Colfax Corporation, Colfax Corporation etc.
What is the salary of Matthew L. Trerotola?
Mr. Matthew L. Trerotola salary is $2,980,000 per year as Pres, Chief Executive Officer & Director in Enovis Corporation. He also receives $2,410,000 as Pres, Chief Executive Officer & Director in Colfax Corporation and salaries from other companies.
How old is Matthew L. Trerotola?
Mr. Matthew L. Trerotola is 58 years old, born in 1967.
What stocks does Matthew L. Trerotola currently own?
As insider, Mr. Matthew L. Trerotola owns shares in 2 companies:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Colfax Corporation (CFX) | Pres, Chief Executive Officer & Director | 413,524 | $39.06 | $16,152,247 |
Colfax Corporation (CFXA) | Pres, Chief Executive Officer & Director | 305,708 | $177.71 | $54,327,369 |
What does Colfax Corporation do?
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
What does Colfax Corporation do?
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is based in Wilmington, Delaware.
Matthew L. Trerotola insider trading
Colfax Corporation
Mr. Matthew L. Trerotola has made 29 insider trades between 2016-2022, according to the Form 4 filled with the SEC. Most recently he sold 12,002 units of CFX stock worth $466,638 on 7 Mar 2022.
The largest trade he's ever made was exercising 200,000 units of CFX stock on 14 May 2021. As of 6 Sep 2025 he still owns at least 413,524 units of CFX stock.
Colfax Corporation
Mr. Matthew L. Trerotola has made 16 insider trades in 2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 200,000 units of CFXA stock on 14 May 2021. As of 6 Sep 2025 he still owns at least 305,708 units of CFXA stock.
Enovis key executives
Enovis Corporation executives and other stock owners filed with the SEC:
- Mr. Bradley J. Tandy Senior Vice President, Gen. Counsel & Sec.
- Mr. Brady R. Shirley (59) Chief Executive Officer of DJO & Executive Vice President
- Mr. Christopher M. Hix (63) Executive Vice President of Fin. & Chief Financial Officer
- Mr. Daniel A. Pryor (57) Executive Vice President of Strategy & Bus. Devel.
- Mr. Matthew L. Trerotola (58) Pres, Chief Executive Officer & Director
- Mr. Mitchell P. Rales (68) Co-Founder & Chairman
- Mr. Shyam Kambeyanda (54) Executive Vice President and Chief Executive Officer & Pres of ESAB
- Mr. Steven L. Breitzka Interim Senior Vice President of Global Operations & Americas
- Mr. Terry Ross Vice President of Investor Relations, Strategy & Bus. Devel.
- Ms. Patricia A. Lang Senior Vice President & Chief HR Officer